Valeria Soberón
Valeria Soberón
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
4Max-Planck Institute of Biochemistry, Planegg, Germany
1,2,3,4,#,
Lena Osswald
Lena Osswald
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
5Department of Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,5,#,
Andrew Moore
Andrew Moore
6Department of Haematology, University of Cambridge, Cambridge, UK
7Cancer Institute, University College London, London, UK
6,7,
Dominika Sosnowska
Dominika Sosnowska
7Cancer Institute, University College London, London, UK
7,
Gene Swinerd
Gene Swinerd
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Jingyu Chen
Jingyu Chen
6Department of Haematology, University of Cambridge, Cambridge, UK
8Department of Biochemistry and Molecular Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, PR China
6,8,
Seren Baygün
Seren Baygün
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
1,2,3,
Carina Diehl
Carina Diehl
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Gönül Seyhan
Gönül Seyhan
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Laura Kraus
Laura Kraus
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Vanessa Gölling
Vanessa Gölling
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Ricarda Trapp
Ricarda Trapp
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Thomas J O’Neill
Thomas J O’Neill
9Research Unit Signaling and Translation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
9,
Sabrina Bortoluzzi
Sabrina Bortoluzzi
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Daniel Kovacs
Daniel Kovacs
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Tim Ammon
Tim Ammon
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Pankaj Singroul
Pankaj Singroul
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Yuliia Hubarzhevska
Yuliia Hubarzhevska
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
1,2,
Rupert Öllinger
Rupert Öllinger
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
10Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, Technical University of Munich, Munich, Germany
2,10,
Sebastian Mueller
Sebastian Mueller
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
10Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, Technical University of Munich, Munich, Germany
2,10,
Olga Baranov
Olga Baranov
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
10Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, Technical University of Munich, Munich, Germany
2,10,
Piero Giansanti
Piero Giansanti
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
11Bavarian Center for Biomolecular Mass Spectrometry at Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany
2,11,
Felix Gillhuber
Felix Gillhuber
12Division of Evolutionary Biology, Faculty of Biology, Ludwig-Maximilians-Universität (LMU) München, Planegg-Martinsried, Germany
12,
Sonja Grath
Sonja Grath
12Division of Evolutionary Biology, Faculty of Biology, Ludwig-Maximilians-Universität (LMU) München, Planegg-Martinsried, Germany
12,
Oliver Weigert
Oliver Weigert
3German Cancer Consortium (DKTK), Heidelberg, Germany
13Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Faculty of Medicine, Department of Medicine III, Ludwig-Maximilians-University, Munich, Germany
3,13,
Andreas Rosenwald
Andreas Rosenwald
14Institute of Pathology, University of Würzburg, Würzburg, Germany
14,
Yoshiteru Sasaki
Yoshiteru Sasaki
15Program in Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA USA
16Division of Immunology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
15,16,
Klaus Rajewsky
Klaus Rajewsky
15Program in Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA USA
17Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
15,17,
Katja Steiger
Katja Steiger
3German Cancer Consortium (DKTK), Heidelberg, Germany
18Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany
3,18,
Florian Bassermann
Florian Bassermann
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
5Department of Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany
19Bavarian Cancer Research Center (BZKF), Munich, Germany
2,3,5,19,
Roland Rad
Roland Rad
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
10Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, Technical University of Munich, Munich, Germany
2,3,10,
Daniel Krappmann
Daniel Krappmann
9Research Unit Signaling and Translation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
9,
Ingo Ringshausen
Ingo Ringshausen
6Department of Haematology, University of Cambridge, Cambridge, UK
7Cancer Institute, University College London, London, UK
6,7,
Marc Schmidt-Supprian
Marc Schmidt-Supprian
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
4Max-Planck Institute of Biochemistry, Planegg, Germany
15Program in Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA USA
1,2,3,4,15,✉
1Institute for Experimental Hematology, School of Medicine and Health, Technical University of Munich, Munich, Germany
2Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University of Munich, Munich, Germany
3German Cancer Consortium (DKTK), Heidelberg, Germany
4Max-Planck Institute of Biochemistry, Planegg, Germany
5Department of Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany
6Department of Haematology, University of Cambridge, Cambridge, UK
7Cancer Institute, University College London, London, UK
8Department of Biochemistry and Molecular Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, PR China
9Research Unit Signaling and Translation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany
10Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, Technical University of Munich, Munich, Germany
11Bavarian Center for Biomolecular Mass Spectrometry at Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany
12Division of Evolutionary Biology, Faculty of Biology, Ludwig-Maximilians-Universität (LMU) München, Planegg-Martinsried, Germany
13Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Faculty of Medicine, Department of Medicine III, Ludwig-Maximilians-University, Munich, Germany
14Institute of Pathology, University of Würzburg, Würzburg, Germany
15Program in Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA USA
16Division of Immunology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
17Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
18Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany
19Bavarian Cancer Research Center (BZKF), Munich, Germany
Subject terms: Chronic lymphocytic leukaemia, B-cell lymphoma, Preclinical research, Lymphoproliferative disorders, B-1 cells
© The Author(s) 2026
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.